Safety Considerations When Combining Ashwagandha and Semaglutide No major direct pharmacokinetic interactions exist between ashwagandha and semaglutide, but several indirect effects warrant attention
Through downregulating monocyte chemoattractant protein-1 expression, semaglutide treatment, an FDA-approved GLP-1 RA medicine targeting Type II diabetes mellitus (T2DM) (Christou et al., 2019), inhibited monocyte migration and infiltration from the circulatory system to inflammatory regions (Pontes-da-Silva et al., 2022)
doi: 10.1111/j.1365-2133.2005.06721.x [2] Frey N, Jossi J, Bodmer M et al
Be well, David Edelberg, MD
However, like any medical treatment, they come with considerations that should be managed thoughtfully
Nothing urgent, but enough to make me think harder about what I was doing for my health